World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
74
Citations
17334
World Ranking
1978
National Ranking
903

John K. Cowell publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where John K. Cowell sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 332 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

John K. Cowell D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where John K. Cowell sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 74 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

John K. Cowell is affiliated with Augusta University in the United States. Their research focuses primarily on medical and molecular biology fields, with significant contributions in hematology, immunology, rheumatology, and genetics. Over their career, they have published extensively on topics including eosinophilic disorders and syndromes, chronic myeloid leukemia treatments, fibroblast growth factor research, acute myeloid leukemia research, immune cells in cancer, myeloproliferative neoplasms diagnosis and treatment, and immune cell function and interaction.

Their recent published papers illustrate a focus on hematological malignancies, leukemia progression, and mechanisms of immune evasion. Notable papers include:

  • "IRAK1-regulated IFN-γ signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies" (2021, Molecular Cancer)
  • "Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem cell leukemia/lymphoma syndrome" (2020, Cell Death and Disease)
  • "Targeting the WASF3 complex to suppress metastasis" (2022, Pharmacological Research)
  • "RHOA-regulated IGFBP2 promotes invasion and drives progression of BCR-ABL1 chronic myeloid leukemia" (2022, Haematologica)
  • "Single-cell analysis defines highly specific leukemia-induced neutrophils and links MMP8 expression to recruitment of tumor associated neutrophils during FGFR1 driven leukemogenesis" (2024, Experimental Hematology and Oncology)

Publications by John K. Cowell have appeared frequently in venues such as Cancer Research, Clinical Lymphoma Myeloma & Leukemia, Molecular Cancer, Cell Death and Disease, and Pharmacological Research. The most frequent publication venues include:

  • Cancer Research
  • Clinical Lymphoma Myeloma & Leukemia
  • Molecular Cancer
  • Cell Death and Disease
  • Pharmacological Research

John K. Cowell collaborates regularly with several researchers, highlighting ongoing partnerships in their field. Frequent coauthors include:

  • Tianxiang Hu
  • Xuexiu Fang
  • Atsuko Matsunaga
  • Baohuan Cai
  • Yating Chong

The main fields of study reflect a multi-disciplinary approach bridging clinical medicine and molecular biology. Contributions to medicine and biochemistry, genetics, and molecular biology are evident. Their work engages with subfields such as molecular biology, hematology, immunology, rheumatology, and genetics, providing insights into mechanisms of blood cancers and immune system interactions.

The research topics addressed cover a range of hematological conditions and molecular pathways, with a notable focus on:

  • Eosinophilic Disorders and Syndromes
  • Chronic Myeloid Leukemia Treatments
  • Fibroblast Growth Factor Research
  • Acute Myeloid Leukemia Research
  • Immune cells in cancer
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Immune Cell Function and Interaction

Best Publications

  • Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series

    Meizan Lai;Maartje G M Huijbers;Eric Lancaster;Francesc Graus

  • Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues

    J. Scott;John Kenneth Cowell;M. E. Robertson;L. M. Priestley

  • Double minutes and homogeneously staining regions: gene amplification in mammalian cells

    John K. Cowell

  • Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade

    Maria Ouzounova;Eunmi Lee;Raziye Piranlioglu;Abdeljabar El Andaloussi

  • The TACC domain identifies a family of centrosomal proteins that can interact with microtubules

    Fanni Gergely;Christina Karlsson;Christina Karlsson;Ivan Still;John Cowell

  • Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA

    Seiji Kondo;Yasuko Kondo;Guiying Li;Robert H Silverman

  • Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.

    Andrew B. Lassman;Michael R. Rossi;Jeffrey R. Razier;Lauren E. Abrey

  • Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation

    Seiji Kondo;Yoshikazu Tanaka;Yasuko Kondo;Masahiro Hitomi

  • Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model

    F E Cotter;P Johnson;P Hall;C Pocock

  • A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors.

    Olga B. Chernova;Robert P.T. Somerville;John K. Cowell

  • Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis.

    Yasuko Kondo;Seiji Kondo;Yoshikazu Tanaka;Talat Haqqi

  • Expression of oligodendrocyte progenitor cell antigens by gliomas: Implications for the histogenesis of brain tumors

    Yigal Shoshan;Akiko Nishiyama;Akiko Nishiyama;Ansi Chang;Sverre Mörk

  • Evaluating human cancer cell metastasis in zebrafish

    Yong Teng;Xiayang Xie;Steven Walker;David T White

  • Manipulation of nonsense mediated decay identifies gene mutations in colon cancer Cells with microsatellite instability.

    Yurij Ionov;Norma Nowak;Manuel Perucho;Sanford Markowitz

  • The third member of the transforming acidic coiled coil-containing gene family, TACC3, maps in 4p16, close to translocation breakpoints in multiple myeloma, and is upregulated in various cancer cell lines.

    Ivan H. Still;Pauline Vince;John Kenneth Cowell

  • Tumour suppressor genes

    J. K. Cowell

  • The involvement of JAK-STAT3 in cell motility, invasion, and metastasis.

    Yong Teng;James L Ross;John K Cowell

  • Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype.

    Zerrin Onadim;Annette Hogg;Paul N. Baird;John K. Cowell

  • Cloning of TACC1, an embryonically expressed, potentially transforming coiled coil containing gene, from the 8p11 breast cancer amplicon.

    Ivan H Still;Mark Hamilton;Pauline Vince;Alan Wolfman

  • A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instability.

    Yurij Ionov;Sei Ichi Matsui;John K. Cowell

Frequent Co-Authors

Norma J. Nowak
Norma J. Nowak University at Buffalo, State University of New York
Paul N. Baird
Paul N. Baird University of Melbourne
Gene H. Barnett
Gene H. Barnett Cleveland Clinic
Antonio Baldini
Antonio Baldini University of Naples Federico II
William S. Dynan
William S. Dynan Emory University
Akiko Nishiyama
Akiko Nishiyama University of Connecticut
Muthusamy Thangaraju
Muthusamy Thangaraju Augusta University
Ali S. Arbab
Ali S. Arbab Augusta University
Robert H. Silverman
Robert H. Silverman Kent State University
Bruce A. Roe
Bruce A. Roe University of Oklahoma

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Genetics, there are several related online degrees and alternative career pathways to consider in the broader health and science fields. Nursing is a popular choice, and many aspiring students wonder, do you have to take the teas test to get into nursing school? Some schools offer routes without these exam requirements, making entry more accessible for some applicants.

For those aiming for leadership, pursuing one of the most affordable mha programs online can be a smart step toward advancing your healthcare career. Those looking for a quicker path into nursing might explore fast track lpn programs online, which offer a streamlined curriculum and flexible schedules.

Committed to research or teaching? Earning a phd in nursing can open doors to academic, clinical, and policy-making roles. Whether you pursue genetics directly or a related field, these pathways can expand your career options and allow you to make a meaningful impact in healthcare and science.

Best Scientists Citing John K. Cowell

Trending Scientists

Recently Published Articles